期刊簡介預計審稿時間： 12周，或約稿

ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This reputable peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application.

ASSAY and Drug Development Technologies coverage includes:

-Assay design, target development, and high-throughput technologies-

Hit to Lead optimization and medicinal chemistry through preclinical candidate selection-

Lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis-

Approaches to assays configured for gene families, inherited, and infectious diseases-

Assays and strategies for adapting model organisms to drug discovery-

The use of stem cells as models of disease-

Translation of phenotypic outputs to target identification-

Exploration and mechanistic studies of the technical basis for assay and screening artifacts

《分析和藥物開發(fā)技術(shù)》提供了新技術(shù)和強大工具，可實現(xiàn)早期篩選的關(guān)鍵進展。本期刊上發(fā)表的這項研究為藥物發(fā)現(xiàn)和開發(fā)提供了重要的治療方法和平臺。這本享有盛譽的同行評審期刊刊登原創(chuàng)論文、應用型技術(shù)評論、新興研究領域的專題以及方法和技術(shù)應用報告。

分析和藥物開發(fā)技術(shù)報道包括：

-分析設計、靶標開發(fā)和高通量技術(shù)-

通過臨床前候選藥物選擇實現(xiàn)先導化合物優(yōu)化和藥物化學-

實驗室自動化、樣品管理、生物信息學、數(shù)據(jù)挖掘、虛擬篩選和數(shù)據(jù)分析-

針對基因家族、遺傳和傳染病配置的分析方法-

使模型生物適應藥物發(fā)現(xiàn)的分析和策略-

使用干細胞作為疾病模型-

將表型輸出轉(zhuǎn)化為靶標識別-

分析和篩選制品的技術(shù)基礎探索和機制研究

《Assay And Drug Development Technologies》(檢測和藥物開發(fā)技術(shù))編輯部通訊方式為MARY ANN LIEBERT INC, 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801。如果您需要協(xié)助投稿或潤稿服務，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務十年，熟悉發(fā)表政策，可為您提供一對一投稿指導，避免您在投稿時頻繁碰壁，節(jié)省您的寶貴時間，有效提升發(fā)表機率，確保SCI檢索（檢索不了全額退款）。我們視信譽為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個人信息或稿件內(nèi)容。